Skip to Content

Medications for CMV Prophylaxis

Other names: Cytomegalovirus Prophylaxis

About CMV Prophylaxis:  Cytomegalovirus (CMV) prophylaxis is medication used to prevent the reactivation of CMV infection. CMV is a common virus that infects the majority of people. Once a person has been infected with CMV the virus stays in the body as a dormant or inactive infection and is usually kept in check by the immune system. If the immune system is compromised in some way or lowered, as in the case of immunosuppressive medicines, the infection can be reactivated causing serious illness. The aim of CMV prophylaxis is to keep the CMV suppressed so that it does not cause an active infection.

Drugs Used to Treat CMV Prophylaxis

The following list of medications are in some way related to, or used in the treatment of this condition.

Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
Valcyte C N 1 review
8.0

Generic name: valganciclovir systemic

Drug class: purine nucleosides

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

valganciclovir C N 1 review
8.0

Generic name: valganciclovir systemic

Brand name:  Valcyte

Drug class: purine nucleosides

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

valacyclovir B N 2 reviews
8.0

Generic name: valacyclovir systemic

Drug class: purine nucleosides

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Cytovene C N Add review Rate

Generic name: ganciclovir systemic

Drug class: purine nucleosides

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

ganciclovir C N Add review Rate

Generic name: ganciclovir systemic

Brand name:  Cytovene

Drug class: purine nucleosides

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

CytoGam C N Add review Rate

Generic name: cytomegalovirus immune globulin systemic

Drug class: immune globulins

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

cytomegalovirus immune globulin C N Add review Rate

Generic name: cytomegalovirus immune globulin systemic

Brand name:  CytoGam

Drug class: immune globulins

For consumers: dosage, interactions,

For professionals: AHFS DI Monograph

letermovir N Add review Rate

Generic name: letermovir systemic

Brand name:  Prevymis

Drug class: miscellaneous antivirals

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph

Prevymis N Add review Rate

Generic name: letermovir systemic

Drug class: miscellaneous antivirals

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Page 1

Learn more about CMV Prophylaxis

Micromedex® Care Notes

Legend

Off Label This medication may not be approved by the FDA for the treatment of this condition.
Prescription Only / Over the Counter
Rx Prescription Only
OTC Over the Counter
Rx/OTC Prescription or Over the Counter
Pregnancy
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act Schedule
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Browse Drugs by Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide